Overview
- Description
TILT Biotherapeutics is a clinical-stage biotechnology company developing cancer immunotherapies. The company’s patented technology consists in oncolytic immunotherapies that modify the tumor microenvironment and eliminate its ability to suppress immune responses to cancer.
- Website
- Invested amount
EUR 5 900 000
- Founded
2013
- Project
- Country
- Finland
- Theme
- Health